Shopping Cart
- Remove All
- Your shopping cart is currently empty
Vobramitamab (AEX-4089) is a humanized monoclonal antibody (mAb) targeting the B7-H3 antigen (CD276) which is conjugated to the prodrug seco-duocarmycin hydroxybenzamide azaindole (seco-DUBA) through a enzymatically cleavable peptide-based linker, thereby creating the investigational antibody-drug conjugate (ADC) known as MGC018.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $332 | In Stock | |
5 mg | $929 | In Stock | |
10 mg | $1,490 | In Stock |
Description | Vobramitamab (AEX-4089) is a humanized monoclonal antibody (mAb) targeting the B7-H3 antigen (CD276) which is conjugated to the prodrug seco-duocarmycin hydroxybenzamide azaindole (seco-DUBA) through a enzymatically cleavable peptide-based linker, thereby creating the investigational antibody-drug conjugate (ADC) known as MGC018. |
Targets&IC50 | NB cell lines:17.8-364 ng/mL (IC50) |
Synonyms | AEX-4089, AEX4089 |
Cas No. | 2490556-50-6 |
Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.